187 related articles for article (PubMed ID: 20122159)
1. The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.
Abram ME; Sarafianos SG; Parniak MA
Retrovirology; 2010 Feb; 7():6. PubMed ID: 20122159
[TBL] [Abstract][Full Text] [Related]
2. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
Abram ME; Parniak MA
J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
Sluis-Cremer N; Arion D; Abram ME; Parniak MA
Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
[TBL] [Abstract][Full Text] [Related]
4. Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.
Slack RL; Spiriti J; Ahn J; Parniak MA; Zuckerman DM; Ishima R
Proteins; 2015 Aug; 83(8):1526-38. PubMed ID: 26061827
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
Olivares I; Mulky A; Boross PI; Tözsér J; Kappes JC; López-Galíndez C; Menéndez-Arias L
J Mol Biol; 2007 Sep; 372(2):369-81. PubMed ID: 17651754
[TBL] [Abstract][Full Text] [Related]
6. Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors.
Nishitsuji H; Yokoyama M; Sato H; Yamauchi S; Takaku H
FEBS Lett; 2011 Nov; 585(21):3372-7. PubMed ID: 22004763
[TBL] [Abstract][Full Text] [Related]
7. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation.
Tachedjian G; Moore KL; Goff SP; Sluis-Cremer N
FEBS Lett; 2005 Jan; 579(2):379-84. PubMed ID: 15642347
[TBL] [Abstract][Full Text] [Related]
8. Glutamic residue 438 within the protease-sensitive subdomain of HIV-1 reverse transcriptase is critical for heterodimer processing in viral particles.
Navarro JM; Damier L; Boretto J; Priet S; Canard B; Quérat G; Sire J
Virology; 2001 Nov; 290(2):300-8. PubMed ID: 11883194
[TBL] [Abstract][Full Text] [Related]
9. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
[TBL] [Abstract][Full Text] [Related]
10. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
Mulky A; Vu BC; Conway JA; Hughes SH; Kappes JC
J Mol Biol; 2007 Feb; 365(5):1368-78. PubMed ID: 17141805
[TBL] [Abstract][Full Text] [Related]
11. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.
Boso G; Örvell C; Somia NV
J Virol; 2015 Jan; 89(2):1286-97. PubMed ID: 25392207
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
Hsieh SH; Yu FH; Huang KJ; Wang CT
J Virol; 2023 Sep; 97(9):e0094823. PubMed ID: 37671867
[TBL] [Abstract][Full Text] [Related]
13. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
[TBL] [Abstract][Full Text] [Related]
14. Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its Maturation.
Slack RL; Ilina TV; Xi Z; Giacobbi NS; Kawai G; Parniak MA; Sarafianos SG; Sluis Cremer N; Ishima R
Structure; 2019 Oct; 27(10):1581-1593.e3. PubMed ID: 31471129
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging.
Chiang CC; Tseng YT; Huang KJ; Pan YY; Wang CT
Virology; 2012 Jan; 422(2):278-87. PubMed ID: 22104208
[TBL] [Abstract][Full Text] [Related]
16. Biochemical mechanism of HIV-1 resistance to rilpivirine.
Singh K; Marchand B; Rai DK; Sharma B; Michailidis E; Ryan EM; Matzek KB; Leslie MD; Hagedorn AN; Li Z; Norden PR; Hachiya A; Parniak MA; Xu HT; Wainberg MA; Sarafianos SG
J Biol Chem; 2012 Nov; 287(45):38110-23. PubMed ID: 22955279
[TBL] [Abstract][Full Text] [Related]
17. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.
Schuckmann MM; Marchand B; Hachiya A; Kodama EN; Kirby KA; Singh K; Sarafianos SG
J Biol Chem; 2010 Dec; 285(49):38700-9. PubMed ID: 20876531
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
Stewart L; Vogt VM
Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant.
Huang M; Zensen R; Cho M; Martin MA
J Virol; 1998 Mar; 72(3):2047-54. PubMed ID: 9499059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
